NCT07682389 Etiologic Diagnosis Algorithm in Infective Endocarditis
| NCT ID | NCT07682389 |
| Status | Recruiting |
| Phase | — |
| Sponsor | I.M. Sechenov First Moscow State Medical University |
| Condition | Infective Endocarditis |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2026-01-20 |
| Primary Completion | 2027-02-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2026-01-20 with a primary completion date of 2027-02-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the impact of a diagnostic algorithm combining culture-based and molecular methods on the frequency of etiotropic antibiotic therapy prescription within 14 days of diagnosis of infective endocarditis
Eligibility Criteria
Inclusion Criteria: * Informed consent, * Age ≥ 18, * IE (definite or possible per the 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis) Exclusion Criteria: * Pregnancy/breastfeeding * Unconfirmed or rejected IE diagnosis, * Very high risk of death within 14 days due to severe complications of the main or concomitant disease(s), according to the physician's opinion; * Prior use of antibiotic therapy (except documented treatment failure).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07682389 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Infective Endocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07682389 currently recruiting?
Yes, NCT07682389 is actively recruiting participants. Contact the research team at rachina_s_a@staff.sechenov.ru for enrollment information.
Where is the NCT07682389 trial being conducted?
This trial is being conducted at Moscow, Russia, Moscow, Russia, Moscow, Russia.
Who is sponsoring the NCT07682389 clinical trial?
NCT07682389 is sponsored by I.M. Sechenov First Moscow State Medical University. The trial plans to enroll 128 participants.